Loading organizations...
§ Private Profile · 7 World Trade Ctr, NY, NY 10007
Open-source molecular editor and visualizer for computational chemistry, bioinformatics, and materials science.
Key people at Avogadro Development Corp.
Avogadro Development Corp is a decentralized open-source software organization based around several United States research institutions that oversees the development of a comprehensive cross-platform molecular editor and visualizer. The platform enables academic researchers, students, educators, and industry professionals to build, edit, and analyze complex three-dimensional molecular structures for computational chemistry, bioinformatics, and materials science applications. Supported by academic research grants from the National Science Foundation and the United States Department of Defense, the software has accumulated millions of global downloads across its active user base. The organization operates with institutional support from entities like the University of Pittsburgh and Kitware, recently releasing version 1.99.0 of its completely rewritten Avogadro 2 software in August 2024. The open-source Avogadro project was originally founded in 2007 by key developers Geoffrey Hutchison, Marcus Hanwell, and Donald Ephraim Curtis.
Avogadro Development Corp does not appear in available sources as a distinct entity; the query likely refers to Avogadro, a pharmaceutical company focused on innovative drug development and manufacturing.[1] Established by experienced professionals, it operates under the principle of "Empowering Health beyond Innovation," producing high-quality, affordable medicines like cough syrups (Avocough-LS), calcium supplements (Cal-5G), antibiotics (Realxim-LB, Hardclav), and vitamins (Gadrovit series), adhering to Schedule-M and WHO-GMP standards.[1] With presence in over 23 countries including Europe, Latin America, and CIS regions, it serves global markets through strategic collaborations, emphasizing product quality, availability, and rapid growth.[1]
This positions Avogadro as a portfolio-like company in the pharma sector, solving accessibility issues in medicines via innovative, cost-effective production rather than an investment firm.[1]
Avogadro was founded by a group of committed and experienced professionals united by a vision to transcend mere innovation in healthcare.[1] The company's backstory centers on addressing gaps in medicine quality, availability, and affordability, evolving quickly into a significant player through rigorous manufacturing and international partnerships.[1] Key pivotal moments include strategic collaborations with top European firms to introduce world-class products to India, fueling phenomenal success in a short time.[1] No specific founding year or individual founders are detailed, but its focus has consistently been on expanding a diverse product portfolio while maintaining strict quality controls.[1]
(Note: Other "Avogadro" entities, like a pollution consulting firm [2] or molecular software [3], lack "Development Corp" branding and do not match the pharma profile.[2][3])
Avogadro rides the trend of global pharma democratization, leveraging biotech advancements and international supply chains to deliver affordable innovations amid rising healthcare demands in developing regions.[1] Timing aligns with post-pandemic emphasis on resilient manufacturing and WHO-compliant standards, favoring companies bridging Europe-Asia gaps.[1] Market forces like increasing medicine affordability needs in Latin America/CIS and India's pharma hub status amplify its influence, contributing to the ecosystem by enhancing drug availability and quality benchmarks.[1]
Avogadro is poised for expanded global dominance through more collaborations and product launches, capitalizing on telemedicine and personalized medicine trends.[1] Evolving regulations and AI-driven drug discovery could shape its trajectory, potentially amplifying influence in emerging markets. As a force in accessible health innovation, it ties back to empowering quality medicines worldwide—watch for deeper Asia-Pacific penetration.
Key people at Avogadro Development Corp.
